PATENT CLAIM ANALYSIS

Application Number: 15958192
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "318000"]

Abstract:
One aspect of the invention relates to a series of new PCSK9 inhibitor compounds comprising piperidine ring structures, including compounds of formula (I) and/or pharmaceutically acceptable salts thereof. Another aspect of the invention relates to methods of treating PCSK9 receptor related diseases comprising administration of one or more compounds of formula (I) or a pharmaceutically acceptable salt thereof.

Claim (Index 3):
The compound and/or the pharmaceutically acceptable salt thereof according to  claim 2 , wherein each R 1  is independently chosen from F, Cl, Br, I, OH and NH 2 , or is chosen from Me, Et, phenyl and pyridyl, any of which is optionally substituted by one, two or three R groups.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 91.0
- Lexical Diversity: 1.625
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16317510', '15562825', '16087861', '16326976', '15502356']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.758508223101502
- 35 USC 102 Novelty (BERT): 0.5007943247819154
- Combined Prediction Score: 0.7327368332695434
- Mean Citation Score: 261.95721799999995
- Max Citation Score: 276.37018
- Similarity Product: 257.933971369046

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test